Global Parkinson’s Disease Drug Market Size, Competitive Analysis, Share, Forecast- 2019-2025

The global Parkinson’s disease drug market is anticipated to grow at a CAGR of over 6% during the forecast period. There’s no specific cure available for Parkinson’s disease till now. However, various treatments,supportive therapies, such as physiotherapy, surgery, and drugs are available currently. This expected to support the growth of Parkinson’s disease drug market. Moreover, the additional drugs that provide some relief from the symptoms of Parkinson’s disease to maintain the patient’s quality of life will also drive the Parkinson’s disease drug industry.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/parkinsons-disease-drug-market

Moreover, various research is also going on to find the exact cure for Parkinson’s disease which will significantly drive the Parkinson’s disease drug market. For instance, carbidopa-levodopa is the most effective drug used in Parkinson’s disease for the treatment of symptoms of Parkinson’s. However, as the disease progresses, the drugs starting to wear off in between doses. The symptoms of Parkinson’s disease come back or even cause excessive involuntary movements and the condition becomes more challenging to treat. This presents a major setback for the Parkinson’s disease drug market. 

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market

To minimize the side effects of carbidopa-levodopa, the drug dosage is either adjust or use advanced therapies such as a combination of medications, or in some cases,deep brain stimulation is used. This expected to keep up Parkinson’s disease drug industry. However, all patients didn’t agree on deep brain stimulation or brain surgery. Therefore, UCMA has a device called Duopa pump that delivers medicine consistently throughout the day. 

The duopa pump was FDA approved in 2015 and it is recently getting popular for use. Duopa is carbidopa-levodopa in a gel form. It is constantly administered to the patient using a small infusion pump that delivers the medication slowly all day long. The use of such devices prevents the body from receiving large doses of drugs at once, as it would if it were taken by mouth. Hence, the use of devices such as dopa pump is anticipated to drive the Parkinson’s disease drug market during the forecast period.

Parkinson’s disease is an incurable disorder that has proved various challenges in the process to manage and treat with the available drugs. Hence, disease symptom modification is the ultimate goal for the drug development of Parkinson’s which is driving the market growth.

Global Parkinson’s Disease Drug Market- Segmentation

By Drug Class

  • Dopamine Receptor Agonists
  • MAO-Inhibitors
  • Carbidopa-Levodopa
  • Catechol O-methyltransferase (COMT) Inhibitors
  • Anticholinergics
  • Others